Connect Biopharma (NASDAQ: CNTB) revenue
Connect Biopharma reported revenue of $0.1m for fiscal 2025, 99.8% less than in fiscal 2024 ($26.0m).
Connect Biopharma's best year of the last 3 was fiscal 2024. The biggest drop was in fiscal 2025, −99.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $0.1m | −99.8% | −$58.1m | −90,740.6% |
| 2024 | $26.0m | — | −$22.5m | −86.2% |
| 2023 | $0.0m | — | −$69.1m | — |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Connect Biopharma revenue compared with its sector
By revenue for its latest fiscal year, Connect Biopharma ranks 399th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Connect Biopharma, −99.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 397th | ProKidney | $0.9m | 1,075.0% |
| 398th | Pulse Biosciences | $0.4m | — |
| 399th | Connect Biopharma | $0.1m | −99.8% |
| 400th | Avalo Therapeutics | $0.1m | −86.6% |
| 401st | Altimmune | $0.0m | 105.0% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Connect Biopharma
- How much revenue did Connect Biopharma make in fiscal 2025?
- Connect Biopharma reported revenue of $0.1m for fiscal 2025, compared with $26.0m in fiscal 2024.
- What was the best year for revenue at Connect Biopharma?
- Of its last 3 fiscal years, fiscal 2024, with $26.0m.
- Where does Connect Biopharma rank in its sector by revenue?
- It ranks 399th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Connect Biopharma come from?
- From the annual report (Form 10-K) that Connect Biopharma files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Connect Biopharma files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on Connect Biopharma: the Connect Biopharma page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.